Lessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis Plan

Lessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis Plan

Authors of this article:

Neill KJ Adhikari^{1, 2} ;   Ruxandra Pinto¹ ;   Andrew G Day^{3, 4} ;   Marie-Hélène Masse⁵ ;   Julie Ménard⁵ ;   Sheila Sprague⁶ ;   Djillali Annane^{7, 8, 9} ;   Yaseen M Arabi^{10, 11, 12} ;   Marie-Claude Battista¹³ ;   Dian Cohen^{14, 15} ;   Deborah J Cook^{16, 17, 18} ;   Gordon H Guyatt¹⁸ ;   Daren K Heyland^{19, 20, 21} ;   Salmaan Kanji^{22, 23} ;   Shay P McGuinness^{24, 25, 26} ;   Rachael L Parke^{24, 25, 26, 27} ;   Bharath Kumar Tirupakuzhi Vijayaraghavan^{28, 29} ;   Emmanuel Charbonney^{30, 31} ;   Michaël Chassé^{30, 32} ;   Lorenzo Del Sorbo^{2, 33} ;   Demetrios James Kutsogiannis³⁴ ;   François Lauzier^{35, 36, 37, 38} ;   Rémi Leblanc^{39, 40} ;   David M Maslove^{3, 19, 41} ;   Sangeeta Mehta^{2, 42} ;   Armand Mekontso Dessap^{43, 44, 45} ;   Tina S Mele⁴⁶ ;   Bram Rochwerg^{16, 18} ;   Oleksa G Rewa³⁴ ;   Jason Shahin^{47, 48} ;   Pawel Twardowski⁴⁹ ;   Paul Jeffrey Young^{25, 26, 50} ;   François Lamontagne^{5, 13} ;   LOVIT Investigators⁵¹